Crestline Management »

BioCryst Pharmaceuticals shares owned by Crestline Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Crestline Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 150k 7.60

More positions owned by Crestline Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Denali Therapeutics (DNLI)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Alcoa (AA)
Broadcom (AVGO)
Coherent Corp (COHR)
Norfolk Southern (NSC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Evergy (EVRG)
PPL Corporation (PPL)
NiSource (NI)
Adobe Systems Incorporated (ADBE)
Perrigo SHS (PRGO)
Golar Lng SHS (GLNG)

View all positions for Crestline Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals